Cargando…

Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to icotinib alone

BACKGROUND: To investigate the efficacy and safety of icotinib plus pleurodesis or icotinib alone in epidermal growth factor receptor (EGFR) positive mutant lung cancer patients after malignant pleural effusion (MPE) drainage. METHODS: In this retrospective study from initially reviewed case reports...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yunhua, Fang, Wangsheng, Cheng, Bingye, Chen, Shanshan, Gu, Linping, Zhu, Li, Pan, Yan, Zhou, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330332/ https://www.ncbi.nlm.nih.gov/pubmed/32642157 http://dx.doi.org/10.21037/jtd.2020.03.49

Ejemplares similares

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study
por: Xu, Jianping, et al.
Publicado: (2017)

Combination therapy of apatinib with icotinib for primary acquired icotinib resistance in patients with advanced pulmonary adenocarcinoma with EGFR mutation
por: Xia, Pinghui, et al.
Publicado: (2018)

Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC
por: Zhang, Ningning, et al.
Publicado: (2019)

Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts
por: Cui, Jiadong, et al.
Publicado: (2018)

Efficacy of icotinib in advanced lung squamous cell carcinoma
por: Liang, Shuai, et al.
Publicado: (2018)

Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
por: Ibrahim, Islam M, et al.
Publicado: (2015)

Still’s disease with pleural effusion submitted to a pleurodesis
por: Carvalho, Jozélio, et al.
Publicado: (2021)

An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
por: Zhang, Ying, et al.
Publicado: (2015)

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases
por: Xu, Jian‐ping, et al.
Publicado: (2016)

Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations
por: Yao, Shuyang, et al.
Publicado: (2016)

Complete remission of liver metastasis in a lung cancer patient with epidermal growth factor mutation achieved with Icotinib
por: Zhu, Zhouyu, et al.
Publicado: (2016)

Ambulatory Thoracoscopic Pleurodesis Combined With Indwelling Pleural Catheter in Malignant Pleural Effusion
por: Foo, Chuan T., et al.
Publicado: (2021)

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
por: Xu, Jianping, et al.
Publicado: (2016)

Efficacy and Safety of Povidone-iodine Pleurodesis in Malignant Pleural Effusions
por: Kahrom, Hadi, et al.
Publicado: (2017)

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion
por: Yokoe, Norihito, et al.
Publicado: (2017)

Adverse events after pleurodesis in patients with malignant pleural effusion
por: Terra, Ricardo Mingarini, et al.
Publicado: (2020)

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion
por: Masoud, Hossam Hosny, et al.
Publicado: (2021)

Sequentially administrated of pemetrexed with icotinib/erlotinib in lung adenocarcinoma cell lines in vitro
por: Feng, Xiuli, et al.
Publicado: (2017)

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]
Publicado: (2017)

Icotinib and pemetrexed in treatment of lung adenocarcinoma and the effects on prognostic survival rate of patients
por: Zhou, Xueheng, et al.
Publicado: (2019)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
por: Mao, Long-fei, et al.
Publicado: (2020)

The Combination of Icotinib Hydrochloride and Fluzoparib Enhances the Radiosensitivity of Biliary Tract Cancer Cells
por: Zhu, Linggang, et al.
Publicado: (2020)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
por: Chen, Xiaojie, et al.
Publicado: (2022)

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion
por: Kim, Jeong Eun, et al.
Publicado: (2012)

The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis
por: Hsu, Li-Han, et al.
Publicado: (2020)

Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
por: Fan, Yun, et al.
Publicado: (2017)

Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report
por: Chen, Yu-Qing, et al.
Publicado: (2021)

Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study
por: Chen, Xiaofeng, et al.
Publicado: (2014)

Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib
por: Liang, Jun-Li, et al.
Publicado: (2014)

Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
por: Ye, Chenyang, et al.
Publicado: (2016)

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes
por: Wang, Tao, et al.
Publicado: (2016)

Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
por: Sun, Sheng-Jie, et al.
Publicado: (2022)

Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004)

Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin
por: Rafiei, Rahmatollah, et al.
Publicado: (2014)

Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis
por: Xia, Huan, et al.
Publicado: (2014)

Survival and pleurodesis outcome in patients with malignant pleural effusion – a systematic review
por: Hassan, Maged, et al.
Publicado: (2021)

Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
por: Miao, Zhihua, et al.
Publicado: (2020)

Multimodal approach to the management of malignant pleural effusions: role of thoracoscopy with pleurodesis and tunneled indwelling pleural catheters
por: Agrawal, Abhinav, et al.
Publicado: (2020)

Does attempting talc pleurodesis affect subsequent indwelling pleural catheter (IPC)-related non-draining septated pleural effusion and IPC-related spontaneous pleurodesis?
por: Asciak, Rachelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2seq1tap8184k20t9bm9qjug5n